Literature DB >> 12715918

Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.

Yi Zhu1, Shigeaki Nonoyama, Tomohiro Morio, Masamichi Muramatsu, Tasuku Honjo, Shuki Mizutani.   

Abstract

Thirteen Japanese patients with hyper-IgM syndrome but normal CD40 ligand were characterized. All patients had mutations in AID (activation-induced cytidine deaminase) gene. Five of them had a missense mutation of Arg112His. In all patients, serum IgG, IgA and IgE levels were undetectable, B cells failed to produce detectable amounts of IgE even if cultured them with anti-CD40 and IL-4. Somatic hypermutation (SHM) was also impaired in their peripheral blood B cells. These results suggest that Arg112 is the hot spot of AID mutation and demonstrate that AID plays indispensable roles in class switch recombination (CSR) and somatic hypermutation (SHM) in human B cells. In addition, serum IgM levels in the patients have been continuously high even after proper intravenous immunogloburin infusion (IVIG) and without infection, indicate that AID has the function to induce spontaneous IgM production in B cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12715918

Source DB:  PubMed          Journal:  J Med Dent Sci        ISSN: 1342-8810


  20 in total

Review 1.  Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair.

Authors:  Mala Samaranayake; Janusz M Bujnicki; Michael Carpenter; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

Review 2.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

3.  Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE.

Authors:  Thiago Detanico; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

Review 4.  Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.

Authors:  Xiangxue Meng; Bin Yang; Wen-Chen Suen
Journal:  Innate Immun       Date:  2017-11-13       Impact factor: 2.680

5.  A Severe Anaphylactic Reaction Associated with IgM-Class Anti-Human IgG Antibodies in a Hyper-IgM Syndrome Type 2 Patient.

Authors:  Yuki Tsujita; Kohsuke Imai; Kenichi Honma; Chikako Kamae; Takahiko Horiuchi; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2017-12-19       Impact factor: 8.317

6.  Letter to the editor.

Authors: 
Journal:  Allergy Asthma Clin Immunol       Date:  2006-03-15       Impact factor: 3.406

7.  Hypermutation at A/T sites during G.U mismatch repair in vitro by human B-cell lysates.

Authors:  Phuong Pham; Ke Zhang; Myron F Goodman
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

8.  Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.

Authors:  Asghar Aghamohammadi; Nima Parvaneh; Nima Rezaei; Kasra Moazzami; Sara Kashef; Hassan Abolhassani; Amir Imanzadeh; Javad Mohammadi; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2009-07-03       Impact factor: 8.317

9.  Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.

Authors:  Xiaosheng Wu; Jaime R Darce; Sook Kyung Chang; Grzegorz S Nowakowski; Diane F Jelinek
Journal:  Blood       Date:  2008-08-06       Impact factor: 22.113

10.  A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome.

Authors:  Claudia Fiorini; Sawssen Jilani; Claretta Gioia Losi; Antonietta Silini; Silvia Giliani; Simona Ferrari; Luigi D Notarangelo; Alessandro Plebani; Taher Sfar; Ahmed Helal
Journal:  Eur J Pediatr       Date:  2004-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.